- Home
- CDE vs CPRX Comparison
CDE vs CPRX Comparison
Compare CDE & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDE
- CPRX
- Stock Information
- Founded
- CDE 1928
- CPRX 2002
- Country
- CDE United States
- CPRX United States
- Employees
- CDE N/A
- CPRX N/A
- Industry
- CDE Precious Metals
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- CDE Basic Materials
- CPRX Health Care
- Exchange
- CDE Nasdaq
- CPRX Nasdaq
- Market Cap
- CDE 5.7B
- CPRX 2.6B
- IPO Year
- CDE N/A
- CPRX 2006
- Fundamental
- Price
- CDE $16.27
- CPRX $20.07
- Analyst Decision
- CDE Strong Buy
- CPRX Strong Buy
- Analyst Count
- CDE 4
- CPRX 5
- Target Price
- CDE $9.69
- CPRX $33.20
- AVG Volume (30 Days)
- CDE 13.5M
- CPRX 1.5M
- Earning Date
- CDE 11-05-2025
- CPRX 11-05-2025
- Dividend Yield
- CDE N/A
- CPRX N/A
- EPS Growth
- CDE N/A
- CPRX 183.96
- EPS
- CDE 0.39
- CPRX 1.65
- Revenue
- CDE $1,459,632,000.00
- CPRX $558,499,000.00
- Revenue This Year
- CDE $81.88
- CPRX $16.51
- Revenue Next Year
- CDE $3.81
- CPRX $9.58
- P/E Ratio
- CDE $41.93
- CPRX $12.13
- Revenue Growth
- CDE 63.68
- CPRX 28.55
- 52 Week Low
- CDE $4.58
- CPRX $19.15
- 52 Week High
- CDE $17.15
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- CDE 56.26
- CPRX 46.94
- Support Level
- CDE N/A
- CPRX $19.66
- Resistance Level
- CDE $15.75
- CPRX $20.52
- Average True Range (ATR)
- CDE 0.54
- CPRX 0.67
- MACD
- CDE -0.41
- CPRX 0.02
- Stochastic Oscillator
- CDE 95.15
- CPRX 44.55
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada, and Mexico.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).